Estudios originales

Fear of cancer recurrence and quality of life in early breast cancer survivors: association with clinical and sociodemographic characteristics

Back to article
Scales for measuring fear of cancer recurrence based on patient characteristics.
VariableTotaln (%)Minimunn (%)Moderaten (%)Highn (%)P value
Time from diagnosis0.006
≤ 2 years56 (19%)16 (12%)11 (17%)29 (28%)
2 to 5 years128 (43%)55 (41%)25 (40%)48 (46%)
> 5 years117 (39%)62 (47%)27 (43%)28 (27%)
Age< 0.001
< 50 years52 (17%)2 (1.5%)10 (16%)40 (38%)
50 to 65 years115 (38%)25 (19%)41 (65%)49 (47%)
> 65 years134 (45%)106 (80%)12 (19%)16 (15%)
Educational level< 0.001
Elementary/Middle School, Inc.116 (39%)94 (71%)12 (19%)10 (9.5%)
High School (Full Course)155 (51%)32 (24%)41 (65%)82 (78%)
College30 (10%)7 (5.3%)10 (16%)13 (12%)
Stage0.342
I/II242 (80%)111 (83%)47 (75%)84 (80%)
III59 (20%)22 (17%)16 (25%)21 (20%)
Breast surgery0.718
Segmental mastectomy197 (65%)89 (68%)39 (62%)68 (65%)
Total mastectomy104 (35%)44 (33%)24 (38%)37 (35%)
Axillary surgery0.402
Sentinel lymph node biopsy142 (47%)66 (50%)32 (51%)44 (42%)
Axillary lymph node dissection159 (53%)67 (50%)31 (49%)61 (58%)
ChemotherapyLess than 0.001
No129 (43%)76 (57%)33 (52%)20 (19%)
Yes172 (57%)57 (43%)30 (48%)85 (81%)
Radiation therapy0.098
No44 (15%)26 (20%)7 (11%)11 (10%)
Yes257 (85%)107 (80%)56 (89%)94 (90%)
Hormone theraphy0.024
No25 (8.3%)3 (2.2%)9 (14%)3 (2.9%)
Yes276 (92%)120 (90%)54 (86%)102 (97%)

inc., incomplete.

Data were obtained from the 301 patients included in the study.

Source: Prepared by the authors based on study results.